Delivery Order SPE2DE21D7010-SPE2D626F07KE
Award Date 1/12/26
Potential Completion Date 1/13/26
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., has been awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency (DLA) Medical Supply Chain for the MAXCESS spinal surgical product. The contract, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, employs a fixed-price structure with economic price adjustment provisions. This award carries no set-aside designation, reflecting...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $1,956.60 delivery order (Contract No. 4570300075) by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, for the supply of MAXCESS spinal surgical products. The contract utilizes a fixed-price pricing structure with economic price adjustment mechanisms and carries no set-aside designation, reflecting successful competition in open market procurement....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, with an ultimate completion date of January 6, 2026. The contract is structured as a firm fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting the company's competitive standing in open market federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,033.55 by the Defense Logistics Agency Medical Supply Chain on January 13, 2026, with an ultimate completion date of February 3, 2026. The contract is structured as a firm fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Nuvasive's successful competition in open market...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on December 28, 2025, for the supply of MAXCESS spinal surgical products to support federal healthcare operations. The contract is structured as a fixed-price delivery order with economic price adjustment pricing, valued at $1,389.16, with an ultimate completion date of January 16, 2026. The award was issued by the Defense Logistics Agency Medical Supply Chain,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 26, 2025, for the MAXCESS spinal surgical product line. The contract, which is structured as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of January 5, 2026, and will be performed at Nuvasive's San Diego, California...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order (Contract No. 4570300073) valued at $2,009.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025. The contract covers the delivery of MAXCESS spinal surgical products and related medical devices to support Department of Defense and Department of Veterans Affairs healthcare operations. Structured as a firm...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...